Avinger (NASDAQ:AVGR – Get Free Report) is expected to be issuing its quarterly earnings data before the market opens on Wednesday, March 19th. Analysts expect the company to announce earnings of ($0.40) per share and revenue of $1.86 million for the quarter.
Avinger Price Performance
NASDAQ AVGR opened at $0.47 on Monday. The firm has a market cap of $1.57 million, a PE ratio of -0.04 and a beta of 1.09. Avinger has a one year low of $0.36 and a one year high of $4.37. The stock’s 50 day simple moving average is $0.53 and its 200 day simple moving average is $0.77.
Wall Street Analysts Forecast Growth
Separately, StockNews.com initiated coverage on Avinger in a research report on Monday, March 10th. They set a “hold” rating on the stock.
About Avinger
Avinger, Inc, a commercial-stage medical device company, designs, manufactures, and sells a suite of image-guided and catheter-based systems used by physicians to treat patients with peripheral artery disease (PAD) primarily in the United States and Germany. The company develops lumivascular platform that integrates optical coherence tomography visualization with interventional catheters to provide real-time intravascular imaging during the treatment portion of PAD procedures.
Featured Stories
- Five stocks we like better than Avinger
- How to Evaluate a Stock Before BuyingÂ
- How to Build the Ultimate Everything ETF Portfolio
- 3 Best Fintech Stocks for a Portfolio Boost
- Dutch Bros or Starbucks: Which Coffee Stock Has More Growth?
- Best of the list of Dividend Aristocrats: Build wealth with the aristocrat index
- 3 Stocks With High ROE and Market-Beating Growth Potential
Receive News & Ratings for Avinger Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Avinger and related companies with MarketBeat.com's FREE daily email newsletter.
